Pharmaceutical Glass Packaging Market
Pharmaceutical Glass Packaging Market Forecasts to 2030 - Global Analysis By Product (Vials, Bottles, Cartridges & Syringes and Ampoules), Drug Type (Generic, Branded and Biologic) and By Geography
According to Stratistics MRC, the Global Pharmaceutical Glass Packaging Market is accounted for $20.1 billion in 2023 and is expected to reach $42.9 billion by 2030 growing at a CAGR of 11.4% during the forecast period. The pharmaceutical glass packaging encompasses the production and distribution of glass containers designed to store and protects pharmaceutical products. These glass packaging solutions provide a sterile and impermeable environment that safeguards the integrity, potency, and stability of medications, ensuring they remain effective throughout their shelf life. Pharmaceutical glass packaging comes in various forms, such as vials, bottles, ampoules, and syringes, catering to diverse medication types and delivery methods.
According to the U.S. Centers for Medicare & Medicaid Services, the national health spending of the country is expected to grow at an annual rate of 5.4% and reach USD 6.2 trillion by 2028.
Market Dynamics:
Driver:
Commodity value of glass increased with recyclability
Glass is highly recyclable, and its sustainable nature aligns with increasing environmental concerns. The ability to be infinitely recycled without compromising quality makes glass a preferred choice for eco-conscious consumers and industries. As sustainability becomes a central focus, the demand for products packaged in recyclable materials, such as glass, has risen. This trend not only enhances the market's growth but also underscores the importance of adopting environmentally responsible packaging solutions, bolstering the attractiveness and competitiveness of glass packaging in various sectors.
Restraint:
Limited technological innovations
While industries like plastics have rapidly evolved with new manufacturing techniques and smart packaging solutions, glass packaging has experienced slower progress. This deficiency in innovation restricts the potential for glass to meet modern market demands effectively. Smart packaging features such as tracking, tamper-evidence, and interaction with consumers are less feasible in traditional glass packaging compared to more technologically adaptable materials. Moreover, the pharmaceutical industry's need for specialized packaging, such as controlled drug release systems, can be impeded by glass's relative lack of versatility.
Opportunity:
Growth of pharmaceutical industry in emerging economies
As these regions experience increasing healthcare needs and expanding middle-class populations, there is a higher demand for medicines and corresponding packaging solutions. Glass packaging's ability to ensure drug integrity, stability, and sterility aligns with the stringent quality requirements of pharmaceutical products. Moreover, the focus on sustainability and premium packaging enhances the appeal of glass. Capitalizing on the burgeoning pharmaceutical markets in emerging economies allows glass packaging manufacturers to tap into a significant customer base and contribute to the safe and effective delivery of medications.
Threat:
Increased relevance of alternate material
With innovations in plastics, paper, and other materials, industries are exploring options that offer lighter weight, reduced transportation costs, and improved biodegradability. As sustainability gains prominence, the perceived environmental impact of glass production and transportation might weaken its position. Manufacturers are increasingly pressured to choose materials that align with eco-conscious consumer preferences. This shift towards alternative materials, driven by factors such as cost efficiency and environmental considerations, challenges the traditional dominance of glass in packaging, potentially impacting its market share and growth trajectory.
Covid-19 Impact:
The COVID-19 pandemic experienced supply chain disruptions and a lack of raw materials in several industries, but it had little impact on the pharmaceutical sector. Pharmaceutical businesses were exempt from shutdown restrictions because they are vital to the community. A few of packaging businesses were also exempted from the lockdown limitations and were functioning to produce and support healthcare items. Businesses in the market are responding to the growing demand for packaging for pharmaceutical items connected to COVID-19 by automating their processes and allocating the fewest possible human resources in order to prevent the spread of the virus.
The bottles segment is expected to be the largest during the forecast period
The bottles segment is expected to have a lucrative growth serving as primary containers for various liquid medications and solid dosage forms. Their inert and impermeable properties ensure drug stability and integrity, vital for preserving product efficacy. Bottles come in a range of sizes, from small dropper bottles for precise dosing to larger containers for bulk medications. They offer features such as tamper-evident seals and child-resistant closures, enhancing patient safety. With evolving pharmaceutical needs and a growing focus on patient convenience, bottles play a pivotal role in providing secure and user-friendly packaging solutions that meet stringent regulatory requirements in the pharmaceutical industry.
The generic segment is expected to have the highest CAGR during the forecast period
The generic segment is anticipated to witness the fastest CAGR growth during the forecast period. Generic is non-branded medications that are bioequivalent to their branded counterparts. Generic pharmaceuticals often come in glass packaging, offering cost-effective alternatives while maintaining drug safety and efficacy. Glass containers ensure the stability of generic medicines by providing a barrier against moisture, oxygen, and light, preserving their potency. These packaging solutions contribute to the affordability and accessibility of essential medications. As the demand for generic drugs continues to rise due to healthcare cost containment efforts, pharmaceutical glass packaging plays a pivotal role in delivering high-quality, value-driven healthcare solutions to a broader population.
Region with largest share:
During the forecast period, it is expected that the North America Pharmaceutical Glass Packaging market will continue to hold a majority of the market share. The region's emphasis on patient safety, drug integrity, and product differentiation fuels the demand for high-quality glass containers. With advanced manufacturing capabilities and innovation, North America produces a wide array of pharmaceutical glass packaging solutions, including vials, bottles, and syringes. The presence of major pharmaceutical companies and a well-established healthcare infrastructure drives the adoption of premium packaging options. Additionally, the region's focus on sustainable packaging aligns with global trends, solidifying North America's significant role in shaping the pharmaceutical glass packaging landscape.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period due to its burgeoning pharmaceutical industry and expanding healthcare sector. The region's increasing demand for medicines, along with a growing focus on product safety and preservation, drives the need for high-quality glass packaging solutions. Favorable regulatory landscapes and rising disposable incomes further boost the pharmaceutical glass packaging market. Local manufacturing capabilities, coupled with the presence of key players and innovative technologies, contribute to Asia Pacific's significant role in supplying a wide range of glass containers, vials, and ampoules, essential for maintaining the integrity and efficacy of pharmaceutical products.
Key players in the market
Some of the key players in Pharmaceutical Glass Packaging market include Schott AG, Nipro Corporation, Owens-Illinois, Inc., Arab Pharmaceutical Glass Co., ?i?ecam Group,Stoelzle Oberglas GmbH, West Pharmaceutical Services, Inc., Beatson Clark, Bormioli Pharma S.p.A., Corning Incorporated, Shandong Medicinal Glass Co., Ltd., Ardagh Group S.A, Piramal Enterprises Ltd. and Gerresheimer AG.
Key Developments:
In June 2023, SDG SA announced its partnership with Corning Incorporated to establish a glass tubing facility in Telangana, India. The partnership combined SDG’s expertise with Corning’s glass coating technology to enhance fine-line productivity, thus initiating expansion in pharmaceutical manufacturing.
In May 2023, Bormioli Pharma S.p.A renewed its partnership with Desall.com to develop new innovation and ideas about pharmaceutical packaging by focusing on augment reality solutions for drug delivery, and biometric recognition solutions to transform child-resistant closure systems.
In March 2023, Schott AG launched the production of FIOLAX®amber pharma glass in India with the aim to meet its increasing demand in Asia. This production will improve the reliability, planning, availability, and cost-efficiency of pharmaceutical converters.
Products Covered:
• Vials
• Bottles
• Cartridges & Syringes
• Ampoules
Drug Types Covered:
• Generic
• Branded
• Biologic
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Pharmaceutical Glass Packaging Market, By Product
5.1 Introduction
5.2 Vials
5.2.1 Small vials
5.2.2 Large vials
5.3 Bottles
5.3.1 Small bottles
5.3.2 Large bottles
5.4 Cartridges & Syringes
5.5 Ampoules
6 Global Pharmaceutical Glass Packaging Market, By Drug Type
6.1 Introduction
6.2 Generic
6.3 Branded
6.4 Biologic
7 Global Pharmaceutical Glass Packaging Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Schott AG
9.2 Nipro Corporation
9.3 Owens-Illinois, Inc.
9.4 Arab Pharmaceutical Glass Co.
9.5 ?i?ecam Group
9.6 Stoelzle Oberglas GmbH
9.7 West Pharmaceutical Services, Inc.
9.8 Beatson Clark
9.9 Bormioli Pharma S.p.A.
9.10 Corning Incorporated
9.11 Shandong Medicinal Glass Co., Ltd.
9.12 Ardagh Group S.A
9.13 Piramal Enterprises Ltd.
9.14 Gerresheimer AG
List of Tables
1 Global Pharmaceutical Glass Packaging Market Outlook, By Region (2021-2030) ($MN)
2 Global Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
3 Global Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
4 Global Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
5 Global Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
6 Global Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
7 Global Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
8 Global Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
9 Global Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
10 Global Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
11 Global Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
12 Global Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
13 Global Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
14 Global Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
15 North America Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
16 North America Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
17 North America Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
18 North America Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
19 North America Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
20 North America Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
21 North America Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
22 North America Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
23 North America Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
24 North America Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
25 North America Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
26 North America Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
27 North America Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
28 North America Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
29 Europe Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
30 Europe Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
31 Europe Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
32 Europe Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
33 Europe Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
34 Europe Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
35 Europe Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
36 Europe Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
37 Europe Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
38 Europe Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
39 Europe Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
40 Europe Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
41 Europe Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
42 Europe Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
43 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
44 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
45 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
46 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
47 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
48 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
49 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
50 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
51 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
52 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
53 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
54 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
55 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
56 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
57 South America Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
58 South America Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
59 South America Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
60 South America Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
61 South America Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
62 South America Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
63 South America Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
64 South America Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
65 South America Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
66 South America Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
67 South America Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
68 South America Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
69 South America Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
70 South America Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
71 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
72 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
73 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
74 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
75 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
76 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
77 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
78 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
79 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
80 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
81 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
82 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
83 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
84 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
